Ajanta Pharma Limited Enterprise Value to EBITDA (EV/EBITDA) on July 25, 2025: 26.63

Ajanta Pharma Limited Enterprise Value to EBITDA (EV/EBITDA) is 26.63 on July 25, 2025, a 13.21% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • Ajanta Pharma Limited 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 33.61 on July 25, 2025, which is 26.24% above the current Enterprise Value to EBITDA (EV/EBITDA).
  • Ajanta Pharma Limited 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 22.56 on July 25, 2025, which is -15.26% below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Ajanta Pharma Limited average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 27.27.
Key Data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization